{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T10:13:56Z","timestamp":1784110436140,"version":"3.55.0"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>\n                      Rubinstein-Taybi syndrome type 2 (RSTS2; OMIM #613684) is a rare autosomal dominant disorder caused by loss-of-function variants in the\n                      <jats:italic>EP300<\/jats:italic>\n                      gene (OMIM #602700), characterized by intellectual disability, distinctive craniofacial features, and skeletal anomalies.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Whole-exome sequencing (WES) was performed on five pediatric patients presenting with neurodevelopmental delay. Candidate variants were filtered using the TGex platform and validated by Sanger sequencing for familial segregation analysis. The functional impact of variants was assessed using diverse bioinformatic tools, and pathogenicity classifications were assigned according to ACMG\/AMP guidelines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Five novel\n                      <jats:italic>EP300<\/jats:italic>\n                      variants were identified in this study: c.4774A&amp;gt;G (p.Lys1592Glu), c.4452 + 5G&amp;gt;C, c.3764A&amp;gt;G (p.His1255Arg), c.3591\u20132A&amp;gt;G, and c.6439C&amp;gt;T (p.Gln2147*). These alterations impair gene function through mechanisms including amino acid substitution, disruption of mRNA splicing, or premature protein truncation. All variants were classified as pathogenic or likely pathogenic per ACMG\/AMP criteria. Literature analysis reveals that the predominant clinical manifestations in the Chinese patients encompassed neurodevelopmental impairment, accompanied by motor delay, growth retardation, and microcephaly. Strikingly, archetypal craniofacial dysmorphisms, such as arched eyebrows, long eyelashes, downslanting palpebral fissures, beaked nose, as well as significant skeletal abnormalities were absent, suggesting\n                      <jats:italic>EP300<\/jats:italic>\n                      variants may present with a broader and more variable phenotypic spectrum than previously recognized.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      This study reports five novel pathogenic\n                      <jats:italic>EP300<\/jats:italic>\n                      variants, expanding the variant repertoire of RSTS2 and providing an important basis for clinical diagnosis and genetic counseling.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fgene.2025.1690693","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T22:10:24Z","timestamp":1763590224000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Five novel EP300 variants expand the genetic and phenotypic spectrum of Rubinstein\u2013Taybi syndrome type 2 in Chinese patients"],"prefix":"10.3389","volume":"16","author":[{"given":"Qiang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xunzhao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zailong","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingsi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12881-019-0747-5","article-title":"Rubinstein-taybi syndrome in a Saudi boy with distinct features and variants in both the CREBBP and EP300 genes: a case report","volume":"20","author":"Al-Qattan","year":"2019","journal-title":"BMC Med. Genet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12920-022-01424-4","article-title":"Case report: a Chinese girl like atypical Rubinstein\u2013Taybi syndrome caused by a novel heterozygous mutation of the EP300 gene","volume":"16","author":"Bai","year":"2023","journal-title":"BMC Med. Genomics"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2024.05.03.592353","DOI":"10.1101\/2024.05.03.592353","article-title":"Paralogue-selective degradation of the lysine acetyltransferase EP300","volume":"2024","author":"Chen","year":"2024","journal-title":"bioRxiv"},{"key":"B4","doi-asserted-by":"publisher","first-page":"7002","DOI":"10.1038\/s41467-022-34476-2","article-title":"CBP-HSF2 structural and functional interplay in Rubinstein-Taybi neurodevelopmental disorder","volume":"13","author":"de Thonel","year":"2022","journal-title":"Nat. Commun."},{"key":"B5","doi-asserted-by":"publisher","first-page":"e2192","DOI":"10.1002\/mgg3.2192","article-title":"Novel heterozygous variants in the EP300 gene cause Rubinstein-Taybi syndrome 2: reports from two Chinese children","volume":"11","author":"Du","year":"2023","journal-title":"Mol. Genet. Genomic Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.1002\/ajmg.a.37940","article-title":"Phenotype and genotype in 52 patients with Rubinstein-Taybi syndrome caused by EP300 mutations","volume":"170","author":"Fergelot","year":"2016","journal-title":"Am. J. Med. Genet. A"},{"key":"B7","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1158\/1541-7786.MCR-18-0719","article-title":"CREBBP\/EP300 bromodomain inhibition affects the proliferation of AR-Positive breast cancer cell lines","volume":"17","author":"Garcia-Carpizo","year":"2019","journal-title":"Mol. Cancer Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/j.1399-0004.2010.01535.x","article-title":"Evolutionary evidence of the effect of rare variants on disease etiology","volume":"79","author":"Gorlov","year":"2011","journal-title":"Clin. Genet."},{"key":"B9","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1038\/sj.ejhg.5201594","article-title":"Rubinstein-Taybi syndrome","volume":"14","author":"Hennekam","year":"2006","journal-title":"Eur. J. Hum. Genet."},{"key":"B10","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1101\/gad.351444.123","article-title":"Epigenetic modulators provide a path to understanding disease and therapeutic opportunity","volume":"38","author":"Honer","year":"2024","journal-title":"Genes Dev."},{"key":"B11","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s12920-023-01516-9","article-title":"De novo variation in EP300 gene cause Rubinstein-Taybi syndrome 2 in a Chinese family with severe early-onset high myopia","volume":"16","author":"Huang","year":"2023","journal-title":"BMC Med. Genomics"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1016\/j.jhsa.2014.08.043","article-title":"Rubinstein-Taybi syndrome","volume":"40","author":"Hutchinson","year":"2015","journal-title":"J. Hand Surg. Am."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1516565","DOI":"10.3389\/fgene.2025.1516565","article-title":"Molecular genetic analysis of Rubinstein\u2013Taybi syndrome in Russian patients","volume":"16","author":"Ismagilova","year":"2025","journal-title":"Front. Genet."},{"key":"B14","doi-asserted-by":"publisher","first-page":"657","DOI":"10.14670\/HH-17.657","article-title":"The versatile functions of the transcriptional coactivators p300 and CBP and their roles in disease","volume":"17","author":"Janknecht","year":"2002","journal-title":"Histol. Histopathol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/978-3-319-53889-1_3","article-title":"Rubinstein-Taybi syndrome and epigenetic alterations","volume":"978","author":"Korzus","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1136\/jmg-2023-109438","article-title":"Diagnosis and management in Rubinstein-Taybi syndrome: first international consensus statement","volume":"61","author":"Lacombe","year":"2024","journal-title":"J. Med. Genet."},{"key":"B17","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12881-018-0548-2","article-title":"Rubinstein-Taybi 2 associated to novel EP300 mutations: deepening the clinical and genetic spectrum","volume":"19","author":"L\u00f3pez","year":"2018","journal-title":"BMC Med. Genet."},{"key":"B18","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/B978-0-12-800977-2.00006-1","article-title":"Epigenetic factors in intellectual disability: the Rubinstein-Taybi syndrome as a paradigm of neurodevelopmental disorder with epigenetic origin","volume":"128","author":"Lopez-Atalaya","year":"2014","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.1002\/ajmg.a.37800","article-title":"CREBBP mutations in individuals without Rubinstein-Taybi syndrome phenotype","volume":"170","author":"Menke","year":"2016","journal-title":"Am. J. Med. Genet. A"},{"key":"B20","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1002\/ajmg.a.38626","article-title":"Further delineation of an entity caused by CREBBP and EP300 mutations but not resembling Rubinstein-Taybi syndrome","volume":"176","author":"Menke","year":"2018","journal-title":"Am. J. Med. Genet. A"},{"key":"B21","first-page":"142","article-title":"Arched, clubbed thumb in strong abduction-extension & other concomitant symptoms","volume":"43","author":"Michail","year":"1957","journal-title":"Rev. Chir. Orthop. Reparatrice Appar. Mot."},{"key":"B22","doi-asserted-by":"publisher","first-page":"100299","DOI":"10.1016\/j.xhgg.2024.100299","article-title":"A systematic assessment of the impact of rare canonical splice site variants on splicing using functional and in silico methods","volume":"5","author":"Oh","year":"2024","journal-title":"HGG Adv."},{"key":"B23","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1001\/archpedi.1963.02080040590010","article-title":"Broad thumbs and toes and facial abnormalities. A possible mental retardation syndrome","volume":"105","author":"Rubinstein","year":"1963","journal-title":"Am. J. Dis. Child."},{"key":"B25","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1002\/ccr3.598","article-title":"Whole exome sequencing reveals EP300 mutation in mildly affected female: expansion of the spectrum","volume":"4","author":"Sellars","year":"2016","journal-title":"Clin. Case Rep."},{"key":"B26","article-title":"Rubinstein-Taybi syndrome","volume-title":"GeneReviews\u00ae","author":"Stevens","year":"1993"},{"key":"B27","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.gene.2012.12.105","article-title":"Germline mosaicism in Rubinstein-Taybi syndrome","volume":"518","author":"Tajir","year":"2013","journal-title":"Gene"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.1002\/ajmg.a.61888","article-title":"Rubinstein-Taybi syndrome in diverse populations","volume":"182","author":"Tekendo-Ngongang","year":"2020","journal-title":"Am. J. Med. Genet. A"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e202101217","DOI":"10.26508\/lsa.202101217","article-title":"Nonsense-mediated mRNA decay uses complementary mechanisms to suppress mRNA and protein accumulation","volume":"5","author":"Udy","year":"2022","journal-title":"Life Sci. Alliance"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e2217405120","DOI":"10.1073\/pnas.2217405120","article-title":"EP300 facilitates human trophoblast stem cell differentiation","volume":"120","author":"van Voorden","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B31","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.nbd.2009.10.001","article-title":"Syndromic features and mild cognitive impairment in mice with genetic reduction on p300 activity: differential contribution of p300 and CBP to Rubinstein-Taybi syndrome etiology","volume":"37","author":"Viosca","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"B32","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/mgg3.177","article-title":"CREBBP and EP300 mutational spectrum and clinical presentations in a cohort of Swedish patients with Rubinstein-Taybi syndrome","volume":"4","author":"Wincent","year":"2016","journal-title":"Mol. Genet. Genomic Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"360","DOI":"10.3760\/cma.j.cn511374-20220726-00493","article-title":"A case of Rubinstein-Taybi syndrome caused by a variant of EP300 gene","volume":"40","author":"Yang","year":"2023","journal-title":"Zhonghua Yi Xue Yi Chuan Xue Za Zhi"},{"key":"B34","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3760\/cma.j.cn112140-20230822-00122","article-title":"Clinical and genetic characteristics of 21 children with Rubinstein-Taybi syndrome","volume":"62","author":"Yang","year":"2024","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"B35","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1038\/s41594-018-0114-9","article-title":"The ZZ domain of p300 mediates specificity of the adjacent HAT domain for histone H3","volume":"25","author":"Zhang","year":"2018","journal-title":"Nat. Struct. Mol. Biol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"163","DOI":"10.24272\/j.issn.2095-8137.2017.036","article-title":"EP300 contributes to high-altitude adaptation in Tibetans by regulating nitric oxide production","volume":"38","author":"Zheng","year":"2017","journal-title":"Zool. Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/sj.ejhg.5201791","article-title":"Confirmation of EP300 gene mutations as a rare cause of Rubinstein-Taybi syndrome","volume":"15","author":"Zimmermann","year":"2007","journal-title":"Eur. J. Hum. Genet."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2025.1690693\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T22:10:27Z","timestamp":1763590227000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2025.1690693\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":37,"alternative-id":["10.3389\/fgene.2025.1690693"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2025.1690693","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,20]]},"article-number":"1690693"}}